Verition Fund Management
GILD icon

Verition Fund Management’s Gilead Sciences GILD Stock Holding History

Verition Fund Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.19M Buy
17,300
+6,900
+66% +$909K 0.01% 1053
2026
Q1 		$1.45M Buy
10,400
+1,000
+11% +$140K 0.01% 1169
2025
Q4 		$1.15M Sell
9,400
-32,800
-78% -$3.99M ﹤0.01% 2049
2025
Q3 		$4.68M Buy
42,200
+2,900
+7% +$330K 0.02% 1222
2025
Q2 		$4.36M Buy
39,300
+17,400
+79% +$1.85M 0.02% 1274
2025
Q1 		$2.45M Buy
21,900
+6,300
+40% +$650K 0.01% 1431
2024
Q4 		$1.44M Sell
15,600
-38,200
-71% -$3.44M 0.01% 1786
2024
Q3 		$4.51M Buy
53,800
+8,400
+19% +$641K 0.02% 916
2024
Q2 		$3.11M Buy
45,400
+30,000
+195% +$2M 0.02% 1019
2024
Q1 		$1.13M Buy
+15,400
New +$1.18M 0.01% 1545
2022
Q4 		– Sell
-10,500
Closed -$648K – 2367
2022
Q3 		$648K Buy
+10,500
New +$662K 0.01% 1706
2022
Q2 		– Sell
-50,300
Closed -$2.99M – 2611
2022
Q1 		$2.99M Buy
50,300
+30,400
+153% +$1.94M 0.04% 684
2021
Q4 		$1.45M Buy
+19,900
New +$1.37M 0.01% 1075
2020
Q2 		– Sell
-80,000
Closed -$5.98M – 1095
2020
Q1 		$5.98M Buy
+80,000
New +$5.53M 0.24% 78

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Verition Fund Management's GILD Position: Q2 2026 in Review

Verition Fund Management reduced its Gilead Sciences (GILD) stake by 8.8% in Q2 2026, selling an estimated $77.7K and leaving 6,119 shares worth $773K. The position accounts for ﹤0.01% of the portfolio, ranked #1516.

Verition Fund Management first reported a position in GILD in Q3 2013 and has held it in 39 quarters since. The position peaked at $33.2M in Q1 2025. 2,287 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Verition Fund Management held 6,119 shares of Gilead Sciences worth $773K as of Q2 2026.
  • Verition Fund Management sold 590 Gilead Sciences shares in Q2 2026, an estimated $77.7K.
  • Gilead Sciences made up ﹤0.01% of Verition Fund Management's portfolio in Q2 2026, its #1516 holding.
  • Verition Fund Management first reported a position in Gilead Sciences in Q3 2013 and has held it in 39 quarters since.
  • Verition Fund Management's Gilead Sciences position peaked at $33.2M in Q1 2025.
  • 2,287 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.